CDKN2A and melanoma: In mice, activating RAS mutations have long been established as important models for the genetics of melanoma (Chin et al., 2006), and the NRASQ61K mutation can cooperate with INK4A or ß-catenin mutations to promote melanoma (Ackermann et al., 2005; Delmas et al., 2007).